Introduction
The members of the Ga 12 family, Ga 12 and Ga 13 , were initially isolated as the transforming gep oncogenes (Xu et al., 1993 (Xu et al., , 1994 . Activated mutants of Ga 12 and Ga 13 are extremely potent in inducing neoplastic transformation (Chan et al., 1993; Dhanasekaran and Dermott, 1996; Goldsmith and Dhanasekaran, 2007) . Ga 12 and Ga 13 regulate various cellular processes, such as cell transformation, proliferation, migration, actin-stress fiber formation, neurite retraction, platelet aggregation, gene induction and apoptosis in a context-specific manner (Kawanabe et al., 2002; Kang et al., 2003; Fujii et al., 2005; Kelly et al., 2007) . They regulate small GTP-binding proteins (that is, the Ras and Rho family) through guanine nucleotide exchange factors and modulate the activity of transcription factors, including activating protein 1 (AP-1), serum response factor (SRF), signal transducer and activator of transcription 3 (STAT3), nuclear factor of activated T cells (NFAT) and nuclear factor-kB (Kuner et al., 2002; Kurose, 2003; Fujii et al., 2005; Brown et al., 2006; Kumar et al., 2006; Ki et al., 2007) . The ligands of the G-protein-coupled receptors (GPCRs) that interact with the Ga 12 family members, such as thrombin, angiotensin-II, endothelin-1/2 and thromboxane A 2 , contribute to transdifferentiation and proliferation, as well as hemodynamic alterations (Pinzani et al., 1996; Bataller et al., 2000; Graupera et al., 2003; Fiorucci et al., 2004) .
Transforming growth factor-b1 (TGFb1) is a key mediator that regulates many cellular processes, including epithelial-mesenchymal transition, growth and extracellular matrix (ECM) formation (Friedman, 1993; Qi et al., 1999; Bataller and Brenner, 2005; Zhao et al., 2008) . Although the role of TGFb1 is very intriguing because it acts as both a tumor suppressor and a promoter of invasion and metastasis, it has also been reported that the level of TGFb1 increased in both the blood and urine of hepatocellular carcinoma (HCC) patients, correlating with worsened prognosis and survival, and thus representing an important cancer marker (Giannelli et al., 2005; Fransvea et al., 2008) . The TGFb1 gene is known to be regulated at two levels as follows: transcriptional regulation is orchestrated by transcription factors, whereas post-translational regulation depends on the maturation of precursors bound to TGFb1-binding proteins (Kim et al., 1989; Oklu and Hesketh, 2000; Giannelli et al., 2005; Fransvea et al., 2008) . Regulation of the TGFb1 gene involves AP-1, Zf9, NF1 and SP1 (Kim et al., 1989) .
In the liver, the hepatic stellate cell (HSC) activation coincides with HCC development (Olaso et al., 1997; Lee et al., 2007) . Activated HSCs, which migrate to and accumulate around transformed cells, might be responsible for remodeling and deposition of tumor-associated ECM, and thus be involved in the growth and invasion of HCC cells . Moreover, activated HSCs synthesize not only TGFb1 but also angiogenic factors (Ankoma-Sey et al., 2000) . Results from our laboratory and others show that Ga 12 and/or Ga 13 are responsible for production of inflammatory cytokines and inducible nitric oxide synthase (Kang et al., 2003) , and that certain Ga proteins, such as Ga s , regulate the activation of HSCs (Solis-Herruzo et al., 1998; Kang et al., 2003) . Nevertheless, there have been few studies on the signaling molecules that control the TGFb1 gene in association with G proteins. In particular, no information is available regarding the roles of Ga 12 / Ga 13 in the regulation of the TGFb1 gene or the molecules linking them to gene transcription. This study examined whether or not the gep oncogenes, Ga 12 and Ga 13 , have regulatory roles in TGFb1 gene expression. Here, we used murine embryonic fibroblast (MEF) cells, whose Ga 12 and/or Ga 13 were disrupted, to examine the cell signaling pathways that control TGFb1 gene expression. To investigate the roles of Ga 12 and Ga 13 , Ga 12 and Ga 13 knockout (KO) cells were transfected with plasmids encoding activated mutants of Ga 12 (Ga 12 QL) and Ga 13 (Ga 13 QL), and the levels of TGFb1 and AP-1 transactivation were determined. Moreover, we examined the effects of Ga 12 and Ga 13 deficiency on TGFb1 gene expression in HSCs. In this study, we found that Ga 12 and Ga 13 have regulatory functions in TGFb1 gene induction through Rho/ Rac-dependent AP-1 activation.
Results
Ga 12 /Ga 13 regulation of the basal TGFb1 gene expression The effects of a deficiency in Ga 12 /Ga 13 on TGFb1 gene transcription were examined in MEF cells. Rhodopsin kinase-null (RKÀ/À) MEF cells were used as the KO control in association with the G-protein because the physiological function of RK is restricted to phototransduction (Xu et al., 1997; Ki et al., 2007) . The TGFb1 transcript levels in the RKÀ/À cells were identical to those in wild-type (WT) cells. Semiquantitative reverse transcription PCR (RT-PCR) assays showed that the TGFb1 mRNA level was weakly altered by a deficiency in either Ga 12 or Ga 13 as compared with that in controls, whereas it was completely abolished by a deficiency in both Ga 12 and Ga 13 (Figure 1a, left panel) . A real-time PCR analysis confirmed that TGFb1 gene repression was caused by a Ga 12 /Ga 13 deficiency ( Figure 1a , right panel). Knockdowns of Ga 12 and Ga 13 by siRNA transfection (12 h) also inhibited luciferase expression from pGL3-1132 (TGFb1 luciferase reporter) in MEF cells (Figure 1b, left panel) , which is consistent with the result showing significant inhibition of gene transactivation by simultaneous transfection of minigenes that disturb the GPCR-Ga 12 /Ga 13 coupling by the C-terminal peptide expression of Ga 12 /Ga 13 (Figure 1b , right panel) (Qi et al., 1999; Ki et al., 2007) . TGFb1 gene expression was significantly increased in Ga 12 /Ga 13 À/À cells after transfection of constitutively active mutants of Ga 12 (Ga 12 QL) and Ga 13 (Ga 13 QL) (Figure 1c) . These results provide evidence that Ga 12 and Ga 13 are required for basal TGFb1 gene expression.
Ga 12 /Ga 13 regulation of TGFb1 gene induction by TGFb1 or thrombin Next, we examined the role of Ga 12 and Ga 13 in the autoinduction of the TGFb1 gene. The level of TGFb1 mRNA in control cells gradually increased after TGFb1 treatment, reaching its maximal level at 12 h, and reducing from the maximum at 24 h. In contrast, a deficiency in both Ga 12 and Ga 13 abolished the basal expression level and auto-induction of the gene (Figure 2a , left panel). Similarly, treating control cells with TGFb1 resulted in a marked increase in the level of luciferase expression from a TGFb1 promoter construct, but this was not observed in cells deficient in Ga 12 and Ga 13 (Figure 2a, right panel) . We also confirmed a decrease in TGFb1-inducible TGFb1 gene expression in primary cultured MEFs prepared from Ga 12 /Ga 13 þ /À mice ( Figure 2b ). Previously, we reported the coupling of Ga 12 /Ga 13 with PAR (thrombin receptor) in macrophages (Kang et al., 2003) . TGFb1 mRNA levels in KO MEF cells were measured after thrombin treatment to associate the effect of GPCR ligand with TGFb1 gene induction. As expected, thrombin increased the level of TGFb1 mRNA in control MEF cells. However, this was attenuated by a deficiency in Ga 12 /Ga 13 ( Figure 2c ). These data indicate that Ga 12 and Ga 13 play a role in TGFb1 gene induction not only by TGFb1 but also by thrombin.
Given the decreases in basal and inducible TGFb1 expression by a Ga 12 /Ga 13 deficiency, we next examined whether TGFb1 treatment activates Ga 12 and Ga 13 . As the activated forms of Ga 12 and Ga 13 bind to the tetratricopeptide repeat (TPR) domain of Ser/Thr phosphatase type 5, the interaction between the TPR domain of Ser/Thr phosphatase type 5 and Ga 12 or Ga 13 can be utilized to assess the activation status of the G-proteins (Yamaguchi et al., 2003; Radhika et al., 2005) . GST-TPR pulldown assays showed that TGFb1 treatment did not allow Ga 12 or Ga 13 to bind to the TPR domain ( Figure 2d) (Figure 3a) . Moreover, induction of TGFb1 mRNA by thrombin was also inhibited by a deficiency in Ga 12 /Ga 13 in HSCs (Figure 3b ).
Studies in animal models have shown that exposure to dimethylnitrosamine (DMN), a hepatocarcinogen, causes HSC activation within 3-6 weeks (Jenkins et al., 1985; George and Chandrakasan, 1996; George et al., 2001; Kang et al., 2002a) . In this study, after 4 weeks of DMN treatments, the levels of TGFb1 transcript were measured in the livers of WT or double heterozygous deletion mutants of Ga 12 /Ga 13 (Ga 12 / Ga 13 þ /À) mice. As the Ga 12 members exhibited overlapping roles in transducing the signals for TGFb1 gene expression in vitro, here we focused on double heterozygous deletion mutants of Ga 12 /Ga 13 . A semiquantitative RT-PCR assay showed that hepatic TGFb1 mRNA levels were significantly higher in WT mice after 4 weeks of the DMN treatment compared with vehicle-treated control ( Figure 3c , left panel). It should be noted that the ability of DMN to induce TGFb1 in the liver was almost completely prevented by a Ga 12 and Ga 13 double heterozygous deficiency (Ga 12 /Ga 13 þ /À). The result of RT-PCR analyses confirmed the regulatory role of Ga 12 /Ga 13 in TGFb1 gene expression in the liver (Figure 3c , right panel).
Role of AP-1 in TGFb1 gene expression downstream from Ga 12 /Ga 13
In an effort to study the mechanistic basis of this process, we next explored the regulatory site affected by Ga 12 /Ga 13 in the TGFb1 gene. A series of TGFb1 promoter deletion constructs prepared from the À1.36 kb region were used to examine the role of the DNA response elements, which interact with various transcription factors. The luciferase activities expressed from pGL3-1362, pGL3-1132, pGL3-731 or pGL3-453 were all lower in cells deficient in Ga 12 and Ga 13 compared with their respective controls ( Figure 4a ). However, the expression of TGFb1 from pGL-323 in the absence of Ga 12 and Ga 13 was not statistically different compared with that of controls, suggesting that DNA element(s) located in the region between À453 and À323 bp interact with transcription factor(s) regulated by Ga 12 and Ga 13 . TGFb1 gene regulation by Ga 12 and Ga 13 SJ Lee et al
The role of AP-1 in TGFb1 gene expression was examined in association with Ga 12 /Ga 13 because the region from À323 to À453 bp contains two AP-1 sites, the proximal serving as a critical binding site for gene transcription (Kim et al., 1989; Weigert et al., 2000) . As anticipated, the siRNA knockdowns of Ga 12 and/or Ga 13 caused a decrease in the AP-1 reporter activity (Figure 4b, left panel) . Similarly, transfection of control cells with the Ga 12 and Ga 13 minigenes also resulted in inhibition (Figure 4b , right panel). The AP-1 activity increased in KO cells simultaneously transfected with Ga 12 QL and Ga 13 QL (Figure 4c) , and a Ga 12 /Ga 13 deficiency abrogated a TGFb1-dependent AP-1 reporter activity (Figure 4d , left panel), confirming that Ga 12 and Ga 13 regulate AP-1.
Next, we assessed the causal relationship between AP-1 activation and TGFb1 gene induction using a , and were treated with 5 ng/ml of TGFb1. Pulldown assays were performed as described in the experimental procedure section to assess whether TGFb1 treatment activates Ga 12 /Ga 13 . Overall 10% of total cell lysate was used as an input control. (Figures 5a and b) . Our data identify the role of Rho and Rac in TGFb1 gene transactivation. Consistently, DN-Rho or DN-Rac transfection inhibited the AP-1 activity (Figure 5c ). Moreover, they substantially decreased AP-1 activation induced by Ga 12 QL and Ga 13 QL in cells deficient in Ga 12 and Ga 13 (Figure 5d ). These results showed that Rho and Rac are the downstream effectors responsible for AP-1 activation by Ga 12 and Ga 13 , contributing to TGFb1 gene expression.
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Discussion
TGFb1 signaling is considered as an important hallmark of cancer transdifferentiation and metastasis (Coulouarn et al., 2008 TGFb1 gene regulation by Ga 12 and Ga 13 SJ Lee et al which might be because of the lack of Ga 12 /Ga 13 -dependent autocrine loops, which activate TGFb1 gene expression. In this study, promoter deletion analyses revealed the DNA region responsible for TGFb1 gene repression in the absence of Ga 12 and Ga 13 to be the segment containing the AP-1 boxes. Subsequent experiments on AP-1 DNA-binding and reporter activities using siR-NA, minigenes or activated mutants demonstrated that Ga 12 and Ga 13 may regulate the signal for basal or TGFb1-inducible AP-1 activity. Moreover, the role of AP-1 in TGFb1 induction downstream of Ga 12 and Ga 13 was supported by our specific AP-1 mutation result for gene expression. Our additional gel shift studies indicated that Jun-D might be involved in the AP-1 complex formation for TGFb1 gene expression (unpublished data), which is consistent with an earlier observation (Smart et al., 2006) . We also found that the mRNA levels of Jun-D and of its target genes (matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1) were reduced by a deficiency in Ga 12 /Ga 13 . Hence, Ga 12 and Ga 13 may regulate the remodeling and deposition of ECM, which is essential for the invasion and metastasis of tumor cells. The present results showing the enhanced AP-1 activation by TGFb1 and the repression of inducible AP-1 activity by the absence of Ga 12 /Ga 13 recapitulate the importance of AP-1 in the auto-stimulatory mechanism of TGFb1 gene transcription. This supports the concept that Ga 12 and Ga 13 regulate the basal and TGFb1-inducible activation of AP-1. Our results agree with earlier reports that AP-1 serves as the transcription complex for induction of the TGFb1 gene and inflammatory genes, such as tumor necrosis factor-a, interleukin-1b and -6 (Kim et al., 1989; Rhoades et al., 1992; Dokter et al., 1995; Weigert et al., 2000) .
Our observation that the small GTPases, Rho and Rac, play crucial roles in relaying the signaling by Ga 12 / Ga 13 that results in the AP-1-dependent TGFb1 induction (Figure 5d ) is consistent with the observation that Ga 12 and Ga 13 have been known to regulate specific signaling pathways through Rho family of GTPases (Kurose, 2003; Fujii et al., 2005; Brown et al., 2006) . However, the competitively inhibitory mutants of Rho (DN-Rho) and Rac (DN-Rac) were not able to completely attenuate the basal TGFb1 mRNA levels (Figure 5a ), TGFb1-luciferase activity (Figure 5b) or AP-1 luciferase activity (Figure 5c ). This is fully in agreement with the findings that the expression of TGFb can be regulated by many different pathways that are independent of Ga 12/13 or Rho/Rac (Yue and Mulder, 2000) . Thus, although the basal regulation of TGFb1 levels is not fully dependent on Rho or Rac (Figures 5a-c) , the Ga 12 /Ga 13 -mediated upregulation of AP-1 promoter activity involved in TGFb1 expression is critically dependent on Rho and Rac, as indicated by the observation (Figure 5d ) that DN-Rho and DN-Rac inhibit Ga 12 /Ga 13 -mediated AP-1 luciferase activity by 80 and 60%, respectively. Quiescent HSCs, which lack AP-1 activity, transiently express c-Fos, Fra-1, c-Jun and Jun-B during culture, whereas myofibroblast-like (that is, activated) HSCs show persistent AP-1 activity consisting of Jun-D, Fos-B and Fra-2 (Bahr et al., 1999) . Hence, the Ga 12 /Ga 13 regulation of the TGFb1 gene in HSCs may also be mediated with the AP-1-dependent signaling cascade. As a large amount of TGFb1 is produced from activated HSCs in the liver (Bataller and Brenner, 2005) , these cells may be involved in the growth and migration of HCCs. In fact, HCCs have been shown to accompany HSC activation (Olaso et al., 1997; Lee et al., 2007) . Moreover, co-transplantation of malignant hepatocytes with activated HSCs increases the potency of tumor formation, which might be mediated with activation of the TGFb1 signaling pathway (Mikula et al., 2006) . Thus, TGFb1 produced from activated HSCs during liver disease is likely to be a potent inducer of cellular transformation.
In the hepatic carcinogenesis, HSCs serve as a liverspecific pericyte and contribute to the remodeling and deposition of tumor-associated ECM (Olaso et al., 1997) . In an additional effort to verify the regulatory role of Ga 12 and Ga 13 in TGFb1 gene expression, we examined the TGFb1 mRNA level in the liver of mice challenged with DMN (a hepatocarcinogen). A Ga 12 and Ga 13 double heterozygous deficiency prevented the ability of DMN to increase the TGFb1 mRNA level, which corroborates the findings obtained from cellular models. Moreover, we found the hepatic accumulation of ECM to be inhibited during a deficiency in Ga 12 /Ga 13 (manuscript in preparation), which is consistent with our finding showing decrease in the level of TGFb1 mRNA in HSCs. Our studies also indicated that the level of CYP2E1 after DMN treatments was not significantly different among the KO animals, suggesting that a deficiency in Ga 12 /Ga 13 might not change DMN activation. During the inflammatory period, the destruction of hepatocytes stimulates pro-inflammatory cells to produce toxic cytokines, which then trigger cellular changes, leading to liver disease through HSC activation (Schook et al., 1992; Friedman, 1993; Bataller and Brenner, 2005; Lee et al., 2007) . Our result showing no significant difference in tumor necrosis factor-a levels between WT and Ga 12 /Ga 13 þ /À mice in response to DMN excludes the possibility that a deficiency in Ga 12 / Ga 13 inhibits the tumor necrosis factor-a-dependent inflammatory process.
The vasoconstrictive mediators (for example, thrombin, angiotensin II and endothelin-1/2) induce cell transdifferentiation and proliferation (Pinzani et al., 1996; Bataller et al., 2000; Gaca et al., 2002; Fiorucci et al., 2004) . Blockage of the GPCRs interacting with these ligands attenuates HCC growth and hepatocarcinogenesis through the inhibition of neovascularization (Molteni et al., 2006; Kaufmann et al., 2007; Yoshiji et al., 2007) . In this study, we verified that thrombin treatment increased the level of TGFb1 mRNA in MEFs or HSCs through AP-1, which was attenuated by a deficiency in Ga 12 /Ga 13 . Hence, it is plausible that the Ga 12 and Ga 13 pathway for AP-1 activation becomes more sensitive to elevated levels of the appropriate GPCR ligands, which contribute to TGFb1 production.
Thus, Ga 12 and Ga 13 regulate expression of the TGFb1 gene, and a deficiency in Ga 12 /Ga 13 prevents TGFb1 gene expression through a process mediated by a decrease in AP-1 activity. These observations lend support to the hypothesis that the activation of the GPCR-Ga 12 pathway is associated with TGFb1-mediated transdifferentiation process.
Materials and methods
Cell culture and treatment Immortalized MEFs were generated from genetically engineered mice that contained gene KOs for rhodopsin kinase (RK) and Ga 12 and/or Ga 13 (Xu et al., 1997; Vogt et al., 2003) . RK, whose physiological function is restricted to photoreduction (Xu et al., 1997; Ki et al., 2007) , was used as the KO control in association with G-proteins. As gene expression and induction responses in RKÀ/À MEFs were similar to those in WT MEFs (Ki et al., 2007) , both RKÀ/À and WT MEFs were used as control cells. Cells were grown to 80-90% confluency and were subjected to no more than 20 cell passages. HSCs were isolated from WT or Ga 12 /Ga 13 þ /À mice, according to the published method (Kang et al., 2002b) . After incubation for 7 days, the cells were sub-cultured to a six-well plate for further experiments. The degree of liver perfusion was important to ensure the purity of the HSCs (>95%), which show fully activated myofibroblast-like phenotype in culture. Primary MEFs were isolated from the embryos of WT or Ga 12 /Ga 13 þ /À mice at embryonic days 10 and 12. Experiments were carried out using primary MEF cells between passages 1 and 2. The cells were cultured in Dulbecco's modified Eagle's medium containing 10% of fetal bovine serum, 100 U/ml of penicillin and 100 mg/ml of streptomycin. After serum starvation for 12 h, the cells were treated with 5 ng/ml of TGFb1 (R&D Systems, Minneapolis, MN, USA) or 10 U/ml of thrombin (Calbiochem, San Diego, CA, USA) for the indicated time period.
Animals
Animal experiments were conducted under the guidelines of the Institutional Animal Use and Care Committee at Seoul National University. WT and Ga 12 /Ga 13 þ /À mice at the age of 8 weeks (B30 g body weight) were used for animal experiments (N ¼ 4À6 for each group) (Dr M Simon, Caltech) (Gu et al., 2002) . PCR-based genotyping and immunoblotting confirmed the genotypes (Gu et al., 2002) . To induce the activation of HSCs, mice in each group were treated with vehicle (N ¼ 4) or multiple doses of DMN (10 ml per kg body weight, i.p., N ¼ 6; Sigma Chemical, St Louis, MO, USA) twice per week for 4 weeks, as described earlier (Kang et al., 2002a, b) . The mice were killed on day 28, and total RNA was extracted from the liver.
Semi-quantitative RT and real-time PCR Total RNA was isolated from cells or liver using the improved single-step method of thiocyanate-phenol-chloroform RNA extraction according to the procedures described earlier (Kang et al., 2002b) . RT-PCR was performed using primers specific for TGFb1 (sense primer: 5 0 -CTTCAGCTCCACAGAGAA GAACTGC-3 0 , antisense primer: 5 0 -CACGATCATGTTGGA CAACTGCTCC-3 0 ) (298 bp) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (sense: 5 0 -TCGTGGAGTCTACT GGCGT-3 0 , antisense: 5 0 -GCCTGCTTCACCACCTTCT-3 0 ) (510 bp). Band intensities of the amplified DNAs were compared after visualization on an UV transilluminator. The SYBR Green real-time PCR amplifications were performed in a 96-well GeneAmp PCR System 9700 coupled with an ABI Prism 7000 Sequence Detection System (AB Applied Biosystems, Alameda, CA, USA). The C T values of TGFb1 and GAPDH amplification were obtained by using serially diluted cDNA samples, and samples with the same C T values were used to facilitate equal loading of cDNA.
Transient transfection and luciferase reporter assay MEFs or HSCs were plated at a density of 5 Â 10 5 cells/well in a six-well dish and were transfected with expression constructs, scrambled siRNA (scRNA) or siRNA directed against Ga 12 / Ga 13 (100 pmol each) (Dharmacon, Boulder, CO, USA) using a Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). The culture medium was then changed to the medium containing 1% of fetal bovine serum, and the cells were further incubated for 12 h. The specificity of siRNA was verified by Ga 12 /Ga 13 immunoblotting. The TGFb1 reporter constructs were kindly provided by Dr SJ Kim (National Cancer Institute, Bethesda, MD, USA). The AP-1 reporter plasmid was purchased from Stratagene (La Jolla, CA, USA). Transfected cells were treated with TGFb1 or thrombin for 12 h. Luciferase activities were measured using a dualluciferase assay system (Promega, Madison, WI, USA) (24). In certain experiments, the minigenes (Solis-Herruzo et al., 1998; Byun et al., 2006) or activated mutant constructs of Ga 12 /Ga 13 (0.5 mg each) were co-transfected with the reporter gene. For certain knockdown experiments, the cells were cotransfected with scRNA, Ga 12 siRNA and/or Ga 13 siRNA with reporter constructs.
GST-TPR pulldown assays
A construct of GST-fused TPR domain was kindly provided by Dr N Dhanasekaran (Temple University, PA, USA). GST-TPR was purified from Escherichia coli, as described earlier (Yamaguchi et al., 2003) . The GST-TPR pulldown assay was carried out according to the previously published method (Radhika et al., 2005) . Briefly, MEF cells were transfected with the construct encoding WT Ga 12 or Ga 13 and were stimulated with TGFb1 for 1-10 min. Cell lysates were incubated with GST-TPR bound to glutathione-Sepharose beads for 3 h at 4 1C. The bound proteins were resolved by SDS-polyacrylamide gel electrophoresis and immunoblotted for Ga 12 or Ga 13 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Ga 12 QL or Ga 13 QL was used as a positive control.
Mutagenesis assay
The proximal AP-1 box in the human TGFb1 gene located between À430 and À396 bp was specifically point-mutated by substituting bases using mutagenic primers (5 0 -TGTTTCCCAGCCTGGTTCTCCTTCCGTTCTGG-3 0 and 5 0 -AAGGGTCGGACCAAGAGGAAGGCAAGACCCAG-3 0 , underlines indicate the mutated nucleotides), according to the manufacturer's instructions (Stratagene, La Jolla, CA, USA) (Weigert et al., 2000) . The DNA sequence of the mutant construct, pGL3-453-DAP-1, was verified by using an automatic DNA sequence analyzer.
Statistical analysis
One-way analysis of variance procedures were used to assess significant differences among treatment groups. For each significant effect of treatment, the Newman-Keuls test was used for comparisons of multiple group means.
